Institutional Ownership
Merck & Co.
CUSIP 58933Y108COMMRKQ1 2026
Latest EPS (Diluted)
$-0.54
Q2 2026 · Jun 30, 2026
Latest Revenue
$16.61B
Reported quarter
Latest Net Income
-$1.33B
Reported quarter
Quarters on Record
12
From SEC XBRL filings
Quarterly Earnings
EPS, revenue & net income · SEC XBRL (10-Q / 10-K)
| Period | Quarter | EPS (Basic) | EPS (Diluted) | Revenue | Net Income | Form |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Q2 2026 | $-0.54 | $-0.54 | $16.61B | -$1.33B | 10-Q |
| Mar 31, 2026 | Q1 2026 | $-1.72 | $-1.72 | $16.29B | -$4.24B | 10-Q |
| Sep 30, 2025 | Q3 2025 | $2.32 | $2.32 | $17.28B | $5.79B | 10-Q |
| Jun 30, 2025 | Q2 2025 | $1.76 | $1.76 | $15.81B | $4.43B | 10-Q |
| Mar 31, 2025 | Q1 2025 | $2.01 | $2.01 | $15.53B | $5.08B | 10-Q |
| Sep 30, 2024 | Q3 2024 | $1.25 | $1.24 | $16.66B | $3.16B | 10-Q |
| Jun 30, 2024 | Q2 2024 | $2.15 | $2.14 | $16.11B | $5.46B | 10-Q |
| Mar 31, 2024 | Q1 2024 | $1.88 | $1.87 | $15.78B | $4.76B | 10-Q |
| Sep 30, 2023 | Q3 2023 | $1.87 | $1.86 | $15.96B | $4.75B | 10-Q |
| Jun 30, 2023 | Q2 2023 | $-2.35 | $-2.35 | $15.04B | -$5.97B | 10-Q |
| Mar 31, 2023 | Q1 2023 | $1.11 | $1.11 | $14.49B | $2.82B | 10-Q |
| Sep 30, 2022 | Q3 2022 | $1.28 | $1.28 | $14.96B | $3.25B | 10-Q |